Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Maiso

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cancers|June 2, 2021
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma ProgressionPatricia Maiso, Pedro Mogollón, Enrique M Ocio, et al.
The Lancet. Oncology|November 29, 2008
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findingsEnrique M Ocio, María-Victoria Mateos, Patricia Maiso, et al.
Journal of Hematology & Oncology|October 9, 2010
Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biologyAntonio Sacco, Ghayas C Issa, Yong Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
microRNA aberrations in Waldenström macroglobulinemiaAntonio Sacco, Yong Zhang, Patricia Maiso, et al.
Cancer Research|June 3, 2006
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistancePatricia Maiso, Xonia Carvajal-Vergara, Enrique M Ocio, et al.
Therapeutic Advances in Hematology|April 5, 2013
The bone marrow microenvironment in waldenstrom macroglobulinemiaIrene M Ghobrial, Patricia Maiso, Abdelkareem Azab, et al.
British Journal of Haematology|March 18, 2008
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cellsPatricia Maiso, Enrique M Ocio, Mercedes Garayoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2012
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaojing Jia, et al.
Cancer Research|March 15, 2015
Metabolic signature identifies novel targets for drug resistance in multiple myelomaPatricia Maiso, Daisy Huynh, Michele Moschetta, et al.
Blood|June 4, 2010
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaoying Jia, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cancers|June 2, 2021
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma ProgressionPatricia Maiso, Pedro Mogollón, Enrique M Ocio, et al.
The Lancet. Oncology|November 29, 2008
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findingsEnrique M Ocio, María-Victoria Mateos, Patricia Maiso, et al.
Journal of Hematology & Oncology|October 9, 2010
Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biologyAntonio Sacco, Ghayas C Issa, Yong Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
microRNA aberrations in Waldenström macroglobulinemiaAntonio Sacco, Yong Zhang, Patricia Maiso, et al.
Cancer Research|June 3, 2006
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistancePatricia Maiso, Xonia Carvajal-Vergara, Enrique M Ocio, et al.
Therapeutic Advances in Hematology|April 5, 2013
The bone marrow microenvironment in waldenstrom macroglobulinemiaIrene M Ghobrial, Patricia Maiso, Abdelkareem Azab, et al.
British Journal of Haematology|March 18, 2008
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cellsPatricia Maiso, Enrique M Ocio, Mercedes Garayoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2012
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaojing Jia, et al.
Cancer Research|March 15, 2015
Metabolic signature identifies novel targets for drug resistance in multiple myelomaPatricia Maiso, Daisy Huynh, Michele Moschetta, et al.
Blood|June 4, 2010
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaoying Jia, et al.
Pageof 5